Anti-inflammatory activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 7, 2005, Pages 1234-1238

  Kou, Junping ^a,b   Sun, Yang ^a   Lin, Yuwen ^b   Cheng, Zhihong ^b   Zheng, Wei ^b   Yu, Boyang ^b   Xu, Qiang ^a  

^a NANJING UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Adhesion; Anti inflammatory activity; Cyclooxygenase 2; Ophiopogon japonicus; Ophiopogonin D; Ruscogenin

Indexed keywords

ACETYLSALICYLIC ACID; CARRAGEENAN; CYCLOOXYGENASE 2; HERBACEOUS AGENT; MESSENGER RNA; OPHIOPOGON ROOT; OPHIOPOGONIN; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT; PROSTAGLANDIN E2; RUSCOGENIN; UNCLASSIFIED DRUG; XYLENE; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG ISOLATION; EDEMA; HUMAN; HUMAN CELL; IC 50; INFLAMMATION; LEUKOCYTE MIGRATION; MOUSE; NEUTROPHIL; NONHUMAN; PAW EDEMA; PERITONITIS; PROTEIN EXPRESSION; RAT;

ACONITUM; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BASE SEQUENCE; CELL LINE; DNA PRIMERS; HUMANS; MALE; MICE; MICE, INBRED ICR; PLANT EXTRACTS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; WATER;

EID: 24944443737     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.1234     Document Type: Article

References (41)

1. Yu B. Y., Xu G. J., J. Chin. Herbs, 26, 205-210 (1995).
2. Xiao P. G., "Modern Chinese Materia Medica," Chemical Industry Press, Beijing, 2002, pp. 77-81.
3. Tada A., Kobayashi M., Shoji J., Chem. Pharm. Bull., 21, 308-311 (1973).
4. Kaneda N., Nakanishi H., Kuraishi T., Katori T., Yakugaku Zasshi, 103, 1133-1139 (1983).
5. Yang Z., Xiao R., Xiao Z. Y., Western China J. Pharm. Sci., 2, 57-60 (1987).
6. Yang Z., Xiao R., Xiao Z. Y., Western China J. Pharm. Sci., 2, 121-124 (1987).
7. Zhu Y. X., Liu L. J., Ling D. K., J. Chin. Materia Medica, 14, 359-360 (1989).
8. Asamo T., Murayama T., Hirai Y., Phytochemistry, 29, 1696-1699 (1990).
9. Asamo T., Murayama T., Hirai Y., Shoji J., Chem. Pharm. Bull., 41, 391-393 (1993).
10. Asano T., Murayama T., Hirai Y., Shoji J., Chem. Pharm. Bull., 41, 566-570 (1993).
11. Guo H. L., Liu J. X., Hang Y. Y., Chin. Wild Plant Resources, 22, 1-4 (2003).
12. Gu S. J., Ji K., Jia J. S., Shanghai J. Trad. Chin. Med., 7, 44-45 (1983).
13. Chen M., Yang Z. M., Zhu J. T., Xiao Z. Y., Xiao R., Acta Pharmacol. Sin., 11, 161-165 (1990).
14. Mo Z. J., Jiang G. C., Ran L., Huang K., Yang Z. W., Xiao R., Xiao Z. Y., Western China J. Pharm. Sci., 6, 13-16 (1991).
15. Chen J. B., Wei H. C., Zhang C., Chin. J. Pathophysiol., 17, 810 (2001).
16. Huang H. C., Ni Z., Cai X. Z., Shanghai Lab. Animal. Sci., 21, 167-168 (2001).
17. Li M., Zhang X., Zhu P., Liu X. F.,Yang J., Forum on Trad. Chin. Med., 16, 43-44 (2001).
18. Guo J., Chen F., Li L. H., Zhao W. M., J. Chin. Microcirc., 6, 246 (2002).
19. Huang H. C., Ni Z., Shanghai Lab. Animal. Sci., 23, 57-58 (2003).
20. Zhang X., Gong J. N., Bian H. M., Xu D. Q., Xiang X. R., Xu H. Q., Yang J.,Wang X. H., J. Nangjing Trad. Chin. Med. Uni. (Nat. Sci.), 17, 289-290 (2001).
21. Zhou H. F., Wu D. Q., Zhang X., Zhejiang J. Trad. Chin. Med., 13, 531-533 (2003).
22. Zhang X., Zhang C. Y., Wang W., Xu D. Q., Yang J., Chin. J. Pathophysio., 19, 789-791 (2003).
23. Zhou Y. H., Xu D. S., Feng Y., Fang J., Xia H. L., Liu J., Luo Y. Q., Ni J. N., Xie Q. Q., Chin. J. Exp. Trad. Med. Formulae, 9, 22-23 (2003).
24. Tian Y. Q., Yu B. Y., Kou J. P., Chin. J. Acad. Med. Mag. Organ., 3, 1-4 (2004).
25. Xu Q., Wang R., Yu B. Y., J. China Pharm. Uni., 24, 98-101 (1993).
26. Wang H. Y., Yu B. Y., Liu J., Men X. Y., J. China Pharm. Uni., 32, 384-389 (2001).
27. Liu J. L., Chen T., Yu B. Y., Xu Q., J. Pharm. Phmarmcol., 54, 959-966 (2002).
28. Dai Y., Liu L. H., Kou J. P., J. China Pharm. Uni., 6, 362-364 (1995).
29. Sandra R. T., Tania S. F., Geisson M. N., Natalio V., Rennee R., Pascual F., Rosa M. R., Roseli C. F., Eur. J. Pharmcol., 408, 199-211 (2000).
30. Chen Q., "Methodology for Studies on Pharmacology of Chinese Materia Medica," The peoples medical publishing house, Bejing, 1993, pp. 370-371.
31. Getting S. J., Flower R. J., Perretti M., Br. J. Pharmacol., 120, 1075-1082 (1997).
32. Moreno J. J., J. Pharm. Exp. Ther., 296, 884-889 (2001).
33. Camping B. G., Pym J., Galbraith P., Cole S., Leukemia Res., 12, 823-831 (1988).
34. Mitsui G., Hirano T., Niwano Y., Mitsui K., Ohara O., Yanagihara S., Int. Immunopharmacol., 4, 57-69 (2004).
35. Luber-Narod J., Austin-Ritchie T., Hollins C., Menon M., Malhotra R. K., Baker S., Carraway R. E., Urol. Res., 25, 395-399 (1997).
36. Campos R. O., Alves R. V., Ferrera J., Kyle D. J., Chakravarty S., Mavnkel B. J., Calixto J. B., Naunyn-Schmiedeberg's Arch. Pharmacol., 360, 278-286 (1999).
37. Henriques M. G., Silva P. M., Martin M. A., Flories C. A., Cunha F. Q., Assreuy-Filho J., Corderio R. S., Braz. J. Med. Biol. Res., 20, 243-249 (1987).
38. Geng J. G., Acta Pharmacol. Sin., 24, 1297-1300 (2003).
39. Springer T. A., Annu. Rev. Physiol., 57, 827-872 (1995).
40. Paya M., Garcia P. P., Coloma J., Alcaraz M. J., Br. J. Pharmacol., 120, 1445-1452 (1997).
41. Nantel F., Denis D., Gordon R., Northey A., Cirino M., Metters K. M., Chan C. C., Br. J. Pharmacol., 128, 853-859 (1999).